Plus Therapeutics Inc.

NASDAQ: PSTV · Real-Time Price · USD
0.63
0.09 (16.19%)
At close: Aug 15, 2025, 3:59 PM

Plus Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
5.82M 4.91M 224K n/a
Cost of Revenue
852K 9.69M 712K 66K
Gross Profit
4.97M -4.78M -488K -66K
Operating Income
-14.7M -13.32M -19.71M -12.49M
Interest Income
273K 400K 147K 19K
Pretax Income
-12.98M -13.32M -20.27M -13.4M
Net Income
-12.98M -13.32M -20.27M -13.4M
Selling & General & Admin
9.09M 8.54M 10.24M 6.85M
Research & Development
10.58M 9.69M 9.7M 5.32M
Other Expenses
n/a -9.69M -224K 250K
Operating Expenses
19.67M 8.54M 19.71M 12.43M
Interest Expense
3.72M 395K 711K 932K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
20.52M 18.23M 19.94M 12.49M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
6.64M 3.14M 1.75M 804.74K
Shares Outstanding (Diluted)
7.7M 3.14M 1.75M 805.95K
EPS (Basic)
-1.95 -4.24 -11.55 -17.78
EPS (Diluted)
-2.34 -4.24 -11.55 -17.78
EBITDA
-8.4M -12.69M -18.85M -12.05M
EBIT
-9.25M -13.32M -19.56M -12.47M
Depreciation & Amortization
852K 628K 619K 419K